Pan YL - Search Results

1

Continuous release of interleukin 12 from microencapsulated engineered cells for colon cancer therapy.

Zheng S, Xiao ZX, Pan YL, Han MY, Dong Q. Zheng S, et al. Among authors: pan yl. World J Gastroenterol. 2003 May;9(5):951-5. doi: 10.3748/wjg.v9.i5.951. World J Gastroenterol. 2003. PMID: 12717836 Free PMC article.

2

[The microencapsulated genetic engineering cells: a new platform on treatment of cancer instead of genetic engineering drugs].

Pan Y, Zheng S. Pan Y, et al. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2003 Jun;20(2):345-7. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2003. PMID: 12856616 Review. Chinese.

3

[Subcutaneous transplantation of microencapsulated Chinese hamster ovary (CHO) cells/pcDNA 3.1/mIL-12 and subcutaneous transplantation of microencapsulated CHO/pcDNA3.1/mIL-12 combined with 5-fluoro-uracil in treatment of tumor-burdened mice].

Pan YL, Zheng S, Xiao ZX, Cao J, Yao HP. Pan YL, et al. Zhonghua Yi Xue Za Zhi. 2003 Jan 10;83(1):51-4. Zhonghua Yi Xue Za Zhi. 2003. PMID: 12757646 Chinese.

4

[Effects of microencapsulated CHO cells modified with maspin gene on the motility and adhesiveness of breast carcinoma cells Bcap37].

Pan YL, Zheng S, Peng JP, Dong Q. Pan YL, et al. Zhonghua Zhong Liu Za Zhi. 2005 Jun;27(6):342-6. Zhonghua Zhong Liu Za Zhi. 2005. PMID: 16117896 Chinese.

5

[Influence of microencapsulated ovary cells modified with maspin gene on the microvessel density and lung metastasis of breast carcinoma].

Pan YL, Zheng S, Peng JP, Dong Q. Pan YL, et al. Zhonghua Yi Xue Za Zhi. 2008 Jan 8;88(2):92-5. Zhonghua Yi Xue Za Zhi. 2008. PMID: 18353211 Chinese.

6

Survival and prognostic factors analysis in surgically resected gastrointestinal stromal tumor patients.

Song Z, Wang JL, Pan YL, Tao DY, Gan MF, Huang KE. Song Z, et al. Among authors: pan yl. Hepatogastroenterology. 2009 Jan-Feb;56(89):149-53. Hepatogastroenterology. 2009. PMID: 19453047

7

Secondary C-kit mutation is a cause of acquired resistance to imatinib in gastrointestinal stromal tumor.

Zheng S, Pan YL, Tao DY, Wang JL, Huang KE. Zheng S, et al. Among authors: pan yl. Scand J Gastroenterol. 2009;44(6):760-3. doi: 10.1080/00365520802647459. Scand J Gastroenterol. 2009. PMID: 19096980

8

Maintenance Therapy in Ovarian Cancer with Targeted Agents Improves PFS and OS: A Systematic Review and Meta-Analysis.

Qian X, Qin J, Pan S, Li X, Pan Y, Ma S. Qian X, et al. PLoS One. 2015 Sep 24;10(9):e0139026. doi: 10.1371/journal.pone.0139026. eCollection 2015. PLoS One. 2015. PMID: 26402447 Free PMC article. Review.

9

[Establishment and pathologic analysis of imatinib-resistant gastrointestinal stromal tumor xenografts].

Zheng S, Wang XJ, Jia J, Pan YL, Tao DY, Lu HS, Huang KE. Zheng S, et al. Among authors: pan yl. Zhonghua Bing Li Xue Za Zhi. 2012 Mar;41(3):176-80. doi: 10.3760/cma.j.issn.0529-5870.2012.03.007. Zhonghua Bing Li Xue Za Zhi. 2012. PMID: 22800481 Chinese.

10

Impact of ABCG2 polymorphisms on the clinical outcome of TKIs therapy in Chinese advanced non-small-cell lung cancer patients.

Chen X, Chen D, Yang S, Ma R, Pan Y, Li X, Ma S. Chen X, et al. Cancer Cell Int. 2015 Apr 19;15:43. doi: 10.1186/s12935-015-0191-3. eCollection 2015. Cancer Cell Int. 2015. PMID: 25960692 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

298 results

Search Page

Filters